EAM Global Investors’s PAVmed PAVM Stock Holding History

EAM Global Investors’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-833	Closed	-$3.2M	–	243
2021 Q3	$3.2M	Hold	833	–	–	0.76%	31
2021 Q2	$2.4M	Buy	+833	New	+$1.97M	0.66%	61

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

EAM Global Investors's PAVM Position: Q4 2021 in Review

EAM Global Investors sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 833 shares — an estimated $3.2M sold.

EAM Global Investors first reported a position in PAVM in Q2 2021 and held it in 2 quarters. The position peaked at $3.2M in Q3 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

EAM Global Investors reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
EAM Global Investors sold 833 PAVmed shares in Q4 2021, an estimated $3.2M.
EAM Global Investors first reported a position in PAVmed in Q2 2021 and held it in 2 quarters.
EAM Global Investors's PAVmed position peaked at $3.2M in Q3 2021.
105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on EAM Global Investors's 13F filing for Q4 2021, filed 11 Feb 2022.